Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis.
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 2, p. 55, doi. 10.2165/00044011-200626020-00001
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2006 AND VI 26 AND IP 2
Results: 6
1
2
Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone Density and Turnover in Postmenopausal Women with Osteoporosis: Results of FACTS1 1 Fosamax Actonel Comparison Trials. -International.
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 2, p. 63, doi. 10.2165/00044011-200626020-00002
- By:
- Publication type:
- Article
3
Healthcare Use, Social Burden and Costs of Children With and Without ADHD in Flanders, Belgium.
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 2, p. 75, doi. 10.2165/00044011-200626020-00003
- By:
- Publication type:
- Article
4
Linguistic Adaptation and Validation of the Spanish Version of the Benign Prostatic Hyperplasia-Patient Impact Measure (BPH-PIM<sup>®</sup>).
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 2, p. 103, doi. 10.2165/00044011-200626020-00005
- By:
- Publication type:
- Article
5
Topiramate Therapy for Symptomatic Trigeminal Neuralgia.
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 2, p. 113, doi. 10.2165/00044011-200626020-00006
- By:
- Publication type:
- Article
6
Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension: A Multicentre, Randomised, Open Study
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 2, p. 91, doi. 10.2165/00044011-200626020-00004
- By:
- Publication type:
- Article